Skip to content

Division of Cardiovascular Diseases

Our Cardiovascular Diseases Division is committed to outstanding education and training, innovations in research and therapeutics, as well as excellence in clinical care. We seek to provide exceptional training in patient-centered care that is supported by a comprehensive understanding of pathophysiology and the best available science. Our basic, translational and clinical researchers aim to discover and implement new approaches for treating and preventing disease. Our cardiologists provide superb, advanced clinical care to patients with the full spectrum of cardiovascular diseases, in a variety of emergent and out-patient venues.

 

UTHSC and Regional One Health Collaborate to Bring Promising COVID-19 Treatment Clinical Trial to Memphis

Cardiology chair

The University of Tennessee Health Science Center and Regional One Health today are announcing that they are partnering on a clinical trial program including two late-stage clinical trials evaluating Regeneron’s REGN-COV2, the company’s investigational two-antibody cocktail for the treatment and prevention of COVID-19.

Leading the efforts are John Jefferies, MD, MPH, FAAP, FACC, FAHA, FHFSA, Jay Michael Sullivan Distinguished Chair in Cardiology, and professor and chief of the Division of Adult Cardiovascular Diseases at UTHSC, and Amber Thacker, MD, an assistant professor of Medicine and Pediatrics at UTHSC and medical director of the Hospital Medicine Service at Regional One Health.

 Read More

More Division of Cardiology News

Last Published: Sep 28, 2020